Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-12-01
2011-11-29
Carlson, Karen (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C536S023100, C514S350000
Reexamination Certificate
active
08067200
ABSTRACT:
A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described.
REFERENCES:
patent: 5668255 (1997-09-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 5998375 (1999-12-01), Thorgersen et al.
patent: 6136564 (2000-10-01), Kopetzki
patent: 6395513 (2002-05-01), Foster
patent: 6461617 (2002-10-01), Shone
patent: 6632440 (2003-10-01), Quinn
patent: 6776990 (2004-08-01), Sachs
patent: 6843998 (2005-01-01), Steward
patent: 6962703 (2005-11-01), Foster
patent: 7052702 (2006-05-01), Duggan
patent: 7056729 (2006-06-01), Donovan
patent: 7132259 (2006-11-01), Dolly
patent: 7192596 (2007-03-01), Shone
patent: 7208466 (2007-04-01), Foster
patent: 7244436 (2007-07-01), Donovan
patent: 7244437 (2007-07-01), Donovan
patent: 7262291 (2007-08-01), Donovan
patent: 7276473 (2007-10-01), Sachs
patent: 7413742 (2008-08-01), Donovan
patent: 7419676 (2008-09-01), Dolly
patent: 7422877 (2008-09-01), Dolly
patent: 7452543 (2008-11-01), Chaddock
patent: 7494661 (2009-02-01), Sanders
patent: 7514088 (2009-04-01), Steward
patent: 7658933 (2010-02-01), Foster et al.
patent: 7659092 (2010-02-01), Foster et al.
patent: 7709228 (2010-05-01), Dolly
patent: 7736659 (2010-06-01), Donovan
patent: 7740868 (2010-06-01), Steward
patent: 7749514 (2010-07-01), Steward
patent: 7780968 (2010-08-01), Donovan
patent: 7785606 (2010-08-01), Ichtchenko
patent: 7811584 (2010-10-01), Steward
patent: 7833535 (2010-11-01), Donovan
patent: 7887810 (2011-02-01), Foster
patent: 7892560 (2011-02-01), Foster
patent: 7897157 (2011-03-01), Steward
patent: 2003/0049264 (2003-03-01), Foster et al.
patent: 2003/0180289 (2003-09-01), Foster
patent: 2004/0071736 (2004-04-01), Quinn
patent: 2004/0115727 (2004-06-01), Steward
patent: 2005/0095251 (2005-05-01), Steward
patent: 2005/0244435 (2005-11-01), Shone
patent: 2006/0051356 (2006-03-01), Foster
patent: 2006/0110410 (2006-05-01), Shone
patent: 2006/0216283 (2006-09-01), Foster
patent: 2007/0010447 (2007-01-01), Quinn
patent: 2007/0010475 (2007-01-01), Richardson
patent: 2007/0066559 (2007-03-01), Richardson
patent: 2007/0184048 (2007-08-01), Foster
patent: 2007/0184070 (2007-08-01), Shone
patent: 2007/0248626 (2007-10-01), Shone
patent: 2008/0025994 (2008-01-01), Steward
patent: 2008/0032928 (2008-02-01), Quinn
patent: 2008/0032931 (2008-02-01), Steward
patent: 2008/0038274 (2008-02-01), Foster
patent: 2008/0070278 (2008-03-01), North
patent: 2008/0182294 (2008-07-01), Dolly
patent: 2008/0311622 (2008-12-01), Dolly
patent: 2009/0004224 (2009-01-01), Steward
patent: 2009/0005313 (2009-01-01), Steward
patent: 2009/0018081 (2009-01-01), Steward
patent: 2009/0030182 (2009-01-01), Dolly
patent: 2009/0030188 (2009-01-01), Dolly
patent: 2009/0042270 (2009-02-01), Dolly
patent: 2009/0069238 (2009-03-01), Steward
patent: 2009/0081730 (2009-03-01), Dolly
patent: 2009/0087458 (2009-04-01), Dolly
patent: 2009/0104234 (2009-04-01), Francis
patent: 2009/0117157 (2009-05-01), Brin
patent: 2009/0162341 (2009-06-01), Foster
patent: 2010/0034802 (2010-02-01), Foster
patent: 2010/0055761 (2010-03-01), Seed
patent: 2010/0196421 (2010-08-01), Ichtchenko
patent: 2010/0209955 (2010-08-01), Oyler
patent: 2010/0303757 (2010-12-01), Francis
patent: 2010/0303789 (2010-12-01), Francis
patent: 2010/0303791 (2010-12-01), Francis
patent: 2011/0091437 (2011-04-01), Foster
patent: 1 422 240 (2004-05-01), None
patent: WO 96/33273 (1996-10-01), None
patent: 97/07208 (1997-02-01), None
patent: 98/07864 (1998-02-01), None
patent: 99/17806 (1999-04-01), None
patent: WO 00/57897 (2000-10-01), None
patent: 01/14570 (2001-03-01), None
patent: 02/07759 (2002-01-01), None
patent: 2004/024909 (2004-03-01), None
patent: 2005/023309 (2005-03-01), None
patent: 2006/026780 (2006-03-01), None
patent: 2006/059093 (2006-06-01), None
patent: 2006/059105 (2006-06-01), None
patent: 2006/059113 (2006-06-01), None
patent: WO 2006/059113 (2006-06-01), None
patent: 2007/138339 (2007-12-01), None
Sagane et al. 1999; Dichain structure of botulinum neurotoxin: Idnetification of cleavage sites in Types C, D, and F neurotoxin molecules. J. Protein Chemistry 18(8): 995-892.
U.S. Appl. No. 11/798,610, Quinn.
U.S. Appl. No. 08/513,878, filed Dec. 1, 1995, North.
U.S. Appl. No. 09/572,431, filed May 17, 2000, North.
U.S. Appl. No. 11/819,648, filed Jun. 28, 2007, Foster.
Chaddock, et al., “Retargeted Clostridial Endopeptidases : Inhibition of Nociceptive Neurotransmitter Release In vitro, and Antinociceptive Activity in In vivo Models of Pain,” Movement Disorders, 19 :S42-S47 (2004).
Blanc, Jacky P. et al., Examination of the Requirement for an Amphiphilic Helical Structure in B-Endorphin through the Design, Synthesis, and Study of Model Peptides, The Journal of Biological Chemistry, vol. 258, No. 13, 1983, pp. 8277-8284.
Shone, Clifford C. et al., A 50-kDa fragment from the NH2-terminus of the heavy subunit ofClostridium botulinumtype A neurotoxin forms channels in lipid vesicles, Eur. J. Biochem. 167, 175-180, 1987.
Wagner, Ernst et al., Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle, Proc. Natl. Acad. Sci, USA, vol. 89, pp. 7934-7938, 1992.
Plank, Christian et al., The Influence of Endosome-disruptive Peptides on Gene Transfer Using Synthetic Virus-like Gene Transfer Systems, The Journal of Biological Chemistry, vol. 269, No. 17, 1994, pp. 12918-12924.
Dooley, Colette T., et al., Binding and In Vitro Activities of Peptides with High Affinity for the Nociceptin/Orphanin FQ Receptor, ORL1, The Journal of Pharmacology and Experimental Therapeutics, 1997, vol. 283, No. 2, pp. 735-741.
Vergnollie, N. et al., Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway, Nature Medicine, vol. 7, No. 7, 2001, pp. 821-826.
Rizzi, Daniela et al., [Arg14, LYS15]Nociceptin, a Highly Potent Agonist of the Nociceptin/Orphanin FQ Receptor: in Vitro and in Vivo Studies, The Journal of Pharmacology and Experimental Therapeutics, 2002, vol. 300, No. 1 pp. 57-63.
Turton, Kathryn et al., Botulinum and tetanus neurotoxins: structure, function and therapeutic utility, Trends in Biochemical Sciences, vol. 27, No. 11, 2002, pp. 552-558.
Maile, Rebecca et al., Effects of nociceptin and analogues of nociceptin upon spontaneous dorsal root activity recorded from an in vitro preparation of rat spinal cord, Neuroscience Letters 350 (2003) 190-192.
Chaddock, John A. et al., Manipulation of Signal Transduction by Botulinum Neurotoxins and their Derivatives, Current Signal Transduction Therapy, 2007, 2, 221-225.
Guerrini, Remo et al., Address and Message Sequences for the Nociceptin Receptor: A Structure-Activity Study of Nociceptin-(1-13)-peptide amide, J. Med. Chem., 1997, 40, 1789-1793.
Schiavo, Giampietro et al., Neurotoxins Affecting Neuroexocytosis, Physiological Reviews, vol. 80, No. 2, 2000, pp. 717-766.
Xu, X.J. et al., Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications, Neuropeptides, 2000, 34(3&4), 137-147.
Okada, Kazushi et al., Highly Potent Nociceptin Analog Containing the Arg-Lys Triple Repeat, Biochemical and Biophy
Aoki Kei Roger
Chaddock John
Foster Keith
Francis Joseph
Marks Philip
Allergan Inc.
Carlson Karen
Roylance Abrams Berdo & Goodman LLP
Syntaxin Ltd.
LandOfFree
Fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264780